Fresenius Kabi morphine syringes recalled for Dilaudid label mixup
Some Fresenius Kabi morphine sulfate prefilled syringes are labeled as morphine 2 mg/mL but actually contain Dilaudid (hydromorphone) 0.5 mg/0.5 mL. This labeling error could lead to patients receiving the wrong medication and dose. The affected lot is 6402820 with an expiration date of 12/2028.
From the FDA notice · Read the official notice ↗ · All Fresenius Kabi recalls
What to do
- Check your morphine sulfate injection for lot number 6402820 (exp. 12/2028).
- Do not use if the label says Morphine 2 mg/mL but the syringe looks different or unexpected.
- Contact your pharmacy or healthcare provider immediately if you have this lot.
- Return unused syringes to your pharmacy or healthcare facility.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Morphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled syringes, For Intramuscular or Intravenous use, Rx only, Fresenius Kabi, Lake Zurich, IL. Unit of Use NDC Number 76045-004-01; Unit of Sale NDC Number 76045-004-11
- Sold in
- Nationwide
- Made for
- All ages (0 months and older)
Details
- Units affected
- 625500 syringes
- Illnesses reported
- None reported
- Manufactured in
- 3 Corporate Dr, Lake Zurich, IL, United States
- Classification
- Class I
- Recall number
- D-0788-2026
In the FDA's words
- Description
- Morphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled syringes, For Intramuscular or Intravenous use, Rx only, Fresenius Kabi, Lake Zurich, IL. Unit of Use NDC Number 76045-004-01; Unit of Sale NDC Number 76045-004-11 Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL. Lot #: 6402820, Exp. Date 12/2028 Distribution: Nationwide within the USA. Affected quantity: 625500 syringes
- Hazard
- Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
More from Fresenius Kabi
See all- Tyenne (tocilizumab-aazg) injection recalled for glass particles
SeriousFDASep 2, 2026